Drug profile · INN
empagliflozin, metformin hydrochloride
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE
empagliflozin, metformin hydrochloride (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Drug details — empagliflozin, metformin hydrochloride
- US status
- approved
- Class
- —
- Route
- —
- Patents
- 0
- Programs
- 1
- Data quality
- 0.81
Quick answer
empagliflozin, metformin hydrochloride (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
Key facts
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is empagliflozin, metformin hydrochloride?
empagliflozin, metformin hydrochloride (EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE) is an FDA-listed pharmaceutical active ingredient. Current US regulatory status: approved.
What is the brand name for empagliflozin, metformin hydrochloride?
EMPAGLIFLOZIN AND METFORMIN HYDROCHLORIDE is a marketed brand name for empagliflozin, metformin hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of empagliflozin, metformin hydrochloride?
empagliflozin, metformin hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.